Brian T. Powl
Chief Commercial OfficerMr. Brian T. Powl, M.S.,M.B.A., serves as Chief Commercial Officer at Kura Oncology, Inc. since August 2023. He served as Chief Commercial Officer at Fate Therapeutics, Inc. since June 2022 until 2023. He served as Senior Vice President of Marketing at MEI Pharma, Inc. since September 15, 2020 until June 2022. He has vast experience in building commercial brands in hematology and oncology, with a focus on developing and executing patient-focused strategies across sales, marketing and market access for global biotech and pharmaceutical products and has experience in the pharmaceutical and biotechnology industry, including extensive global experience in hematologic malignancies. He holds extensive experience in sales and marketing from leading pharmaceutical and biotech companies, having developed and implemented commercial launches and life cycle strategies for multiple hematologic and solid tumor cancers. He was Vice President, global commercial CAR T lead at Celgene Corporation. Previously, he held other senior level positions at Celgene including leading their flagship multiple myeloma franchise, and earlier held sales and marketing positions at Novartis Oncology, and Centocor, Inc. He holds a BS in Biochemistry from the University of California, San Diego and an MBA in Healthcare Management/Marketing from the Wharton School at the University of Pennsylvania.
Positions
- Company NameKura Oncology, Inc.Stock CodeKURAPositionChief Commercial OfficerColleagues
- TETroy Edward WilsonChairman, CEO & President
- KFKathleen FordChief Operating Officer
- JFJennifer FulkChief Financial Officer
- TDThomas DoyleSenior Vice President of Finance & Accounting
- KMKevan M. ShokatChairman of the Scientific Advisory Board
- TRThomas Robert MalleyIndependent Director
- MTMary T. SzelaIndependent Director
- CACarol A. SchaferIndependent Director
